Alex Gorsky
Alex Gorsky
Stories and features about the former Johnson & Johnson Chairman of the Board and CEO.
Chairman and CEO Alex Gorsky profiled by the Financial Times about Johnson & Johnson’s work on a potential COVID-19 vaccine
The article explores what guided the decision, which is just the latest example of our Chairman and CEO’s people-first approach to leadership at our healthcare company.
What you need to know about Johnson & Johnson’s 2020 first-quarter earnings
Check out this infographic breakdown of the company’s first-quarter 2020 performance, with key highlights from its pharmaceutical, consumer and medical devices businesses.
“I have never seen a moment so rich in collaboration, ingenuity and acts of bravery": Johnson & Johnson announces it has identified a lead COVID-19 vaccine candidate
Chairman & CEO Alex Gorsky shares that the company could have the first batches of a COVID-19 vaccine available for emergency-use authorization in early 2021—a substantially accelerated time frame in comparison to the typical vaccine development process.
What you need to know about Johnson & Johnson’s 2019 fourth-quarter and full-year earnings report
Check out this infographic breakdown of the company’s fourth quarter and annual earnings report, with key performance highlights from its pharmaceutical, consumer and medical devices businesses.
What you need to know about Johnson & Johnson’s 2019 third-quarter earnings
Check out this infographic breakdown of the company’s third-quarter performance, with key highlights from its consumer, pharmaceutical and medical devices businesses.
What you need to know about Johnson & Johnson’s 2019 second-quarter earnings
Check out this infographic breakdown of the company’s second-quarter 2019 performance, with key highlights from its consumer, pharmaceutical and medical devices businesses.
What you need to know about Johnson & Johnson’s 2019 first-quarter earnings
Check out this infographic breakdown of the company’s first-quarter 2019 performance, with key highlights from its consumer, pharmaceutical and medical devices businesses.
What you need to know about Johnson & Johnson’s 2018 full-year earnings report
Check out this infographic breakdown of the company’s annual earnings report, with key performance highlights from its consumer, pharmaceutical and medical devices businesses over the last year.
The power of Our Credo: Johnson & Johnson Chairman and CEO Alex Gorsky reflects on the legacy of the company’s historic mission statement
What helps set Johnson & Johnson apart? One legendary document written in 1943. As Our Credo celebrates its 75th anniversary, Gorsky sat down with author and Wharton professor Adam Grant to delve into the past, present and future of the company’s guiding belief statement.
Putting kids around the globe first: Johnson & Johnson announces a $10 million pledge to UNICEF
It’s one of the company’s largest commitments to date, and it aims to help support the crucial work being done by frontline health workers to help more children grow up healthy.